trial · primary record
Azenosertib
Clinical Stage III Gastric Cancer AJCC v8
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2027-07-08 |
| Primary endpoint | Maximum tolerated dose |
| Registry ID | NCT06364410 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:33.826Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06364410
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.